Search Results Search Sort by RelevanceMost Recent AMA Code Says Feb 2012 AMA Code of Medical Ethics’ Opinions on Confidential Care for Sexually Active Minors and Physicians’ Exercise of Conscience in Refusal of Services AMA Council on Ethical and Judicial Affairs Virtual Mentor. 2012;14(2):118-120. doi: 10.1001/virtualmentor.2012.14.2.coet1-1202. Case and Commentary Feb 2012 Protecting the Confidentiality of Sexually Active Adolescents Xiomara M. Santos, MD Virtual Mentor. 2012;14(2):99-104. doi: 10.1001/virtualmentor.2012.14.2.ccas2-1202. In the Literature Feb 2012 Barriers and Biases: Ethical Considerations for Providing Emergency Contraception to Adolescents in the Emergency Department Rebecca C. Thilo Virtual Mentor. 2012;14(2):121-125. doi: 10.1001/virtualmentor.2012.14.2.jdsc1-1202. History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712.
AMA Code Says Feb 2012 AMA Code of Medical Ethics’ Opinions on Confidential Care for Sexually Active Minors and Physicians’ Exercise of Conscience in Refusal of Services AMA Council on Ethical and Judicial Affairs Virtual Mentor. 2012;14(2):118-120. doi: 10.1001/virtualmentor.2012.14.2.coet1-1202.
Case and Commentary Feb 2012 Protecting the Confidentiality of Sexually Active Adolescents Xiomara M. Santos, MD Virtual Mentor. 2012;14(2):99-104. doi: 10.1001/virtualmentor.2012.14.2.ccas2-1202.
In the Literature Feb 2012 Barriers and Biases: Ethical Considerations for Providing Emergency Contraception to Adolescents in the Emergency Department Rebecca C. Thilo Virtual Mentor. 2012;14(2):121-125. doi: 10.1001/virtualmentor.2012.14.2.jdsc1-1202.
History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712.
